162 related articles for article (PubMed ID: 21295541)
1. Several cardiomyopathy causing mutations on tropomyosin either destabilize the active state of actomyosin or alter the binding properties of tropomyosin.
Mathur MC; Chase PB; Chalovich JM
Biochem Biophys Res Commun; 2011 Mar; 406(1):74-8. PubMed ID: 21295541
[TBL] [Abstract][Full Text] [Related]
2. Some cardiomyopathy-causing troponin I mutations stabilize a functional intermediate actin state.
Mathur MC; Kobayashi T; Chalovich JM
Biophys J; 2009 Mar; 96(6):2237-44. PubMed ID: 19289050
[TBL] [Abstract][Full Text] [Related]
3. Cardiomyopathic tropomyosin mutations that increase thin filament Ca2+ sensitivity and tropomyosin N-domain flexibility.
Heller MJ; Nili M; Homsher E; Tobacman LS
J Biol Chem; 2003 Oct; 278(43):41742-8. PubMed ID: 12900417
[TBL] [Abstract][Full Text] [Related]
4. Long-range effects of familial hypertrophic cardiomyopathy mutations E180G and D175N on the properties of tropomyosin.
Ly S; Lehrer SS
Biochemistry; 2012 Aug; 51(32):6413-20. PubMed ID: 22794249
[TBL] [Abstract][Full Text] [Related]
5. The E117K mutation in β-tropomyosin disturbs concerted conformational changes of actomyosin in muscle fibers.
Karpicheva OE; Redwood CS; Borovikov YS
Arch Biochem Biophys; 2014 May; 549():12-6. PubMed ID: 24657080
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyopathy-associated mutations in tropomyosin differently affect actin-myosin interaction at single-molecule and ensemble levels.
Kopylova GV; Shchepkin DV; Nabiev SR; Matyushenko AM; Koubassova NA; Levitsky DI; Bershitsky SY
J Muscle Res Cell Motil; 2019 Dec; 40(3-4):299-308. PubMed ID: 31643006
[TBL] [Abstract][Full Text] [Related]
7. Relationship between regulated actomyosin ATPase activity and cooperative binding of myosin to regulated actin.
Greene LE; Eisenberg E
Cell Biophys; 1988; 12():59-71. PubMed ID: 2453286
[TBL] [Abstract][Full Text] [Related]
8. Effect of Cardiomyopathic Mutations in Tropomyosin on Calcium Regulation of the Actin-Myosin Interaction in Skeletal Muscle.
Kopylova GV; Shchepkin DV; Borovkov DI; Matyushenko AM
Bull Exp Biol Med; 2016 Nov; 162(1):42-44. PubMed ID: 27878731
[TBL] [Abstract][Full Text] [Related]
9. Myosin surface loop 4 modulates inhibition of actomyosin 1b ATPase activity by tropomyosin.
Lieto-Trivedi A; Dash S; Coluccio LM
Biochemistry; 2007 Mar; 46(10):2779-86. PubMed ID: 17298083
[TBL] [Abstract][Full Text] [Related]
10. The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy.
Li XE; Suphamungmee W; Janco M; Geeves MA; Marston SB; Fischer S; Lehman W
Biochem Biophys Res Commun; 2012 Aug; 424(3):493-6. PubMed ID: 22789852
[TBL] [Abstract][Full Text] [Related]
11. Effects of cardiomyopathic mutations on the biochemical and biophysical properties of the human alpha-tropomyosin.
Hilario E; da Silva SL; Ramos CH; Bertolini MC
Eur J Biochem; 2004 Oct; 271(20):4132-40. PubMed ID: 15479242
[TBL] [Abstract][Full Text] [Related]
12. Troponin is a potential regulator for actomyosin interactions.
Mizuno H; Honda H
J Biochem; 2006 Feb; 139(2):289-93. PubMed ID: 16452317
[TBL] [Abstract][Full Text] [Related]
13. Facilitated cross-bridge interactions with thin filaments by familial hypertrophic cardiomyopathy mutations in α-tropomyosin.
Wang F; Brunet NM; Grubich JR; Bienkiewicz EA; Asbury TM; Compton LA; Mihajlović G; Miller VF; Chase PB
J Biomed Biotechnol; 2011; 2011():435271. PubMed ID: 22187526
[TBL] [Abstract][Full Text] [Related]
14. The effect of the dilated cardiomyopathy-causing mutation Glu54Lys of alpha-tropomyosin on actin-myosin interactions during the ATPase cycle.
Borovikov YS; Karpicheva OE; Avrova SV; Robinson P; Redwood CS
Arch Biochem Biophys; 2009 Sep; 489(1-2):20-4. PubMed ID: 19646950
[TBL] [Abstract][Full Text] [Related]
15. HCM and DCM cardiomyopathy-linked α-tropomyosin mutations influence off-state stability and crossbridge interaction on thin filaments.
Farman GP; Rynkiewicz MJ; Orzechowski M; Lehman W; Moore JR
Arch Biochem Biophys; 2018 Jun; 647():84-92. PubMed ID: 29626422
[TBL] [Abstract][Full Text] [Related]
16. α-Tropomyosin with a D175N or E180G mutation in only one chain differs from tropomyosin with mutations in both chains.
Janco M; Kalyva A; Scellini B; Piroddi N; Tesi C; Poggesi C; Geeves MA
Biochemistry; 2012 Dec; 51(49):9880-90. PubMed ID: 23170982
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
Karibe A; Tobacman LS; Strand J; Butters C; Back N; Bachinski LL; Arai AE; Ortiz A; Roberts R; Homsher E; Fananapazir L
Circulation; 2001 Jan; 103(1):65-71. PubMed ID: 11136687
[TBL] [Abstract][Full Text] [Related]
18. The effect of the Asp175Asn and Glu180Gly TPM1 mutations on actin-myosin interaction during the ATPase cycle.
Rysev NA; Karpicheva OE; Redwood CS; Borovikov YS
Biochim Biophys Acta; 2012 Feb; 1824(2):366-73. PubMed ID: 22155441
[TBL] [Abstract][Full Text] [Related]
19. Dual effects of tropomyosin and troponin-tropomyosin on actomyosin subfragment 1 ATPase.
Lehrer SS; Morris EP
J Biol Chem; 1982 Jul; 257(14):8073-80. PubMed ID: 6123507
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyopathy Mutation Alters End-to-End Junction of Tropomyosin and Reduces Calcium Sensitivity.
Sundar S; Rynkiewicz MJ; Ghosh A; Lehman W; Moore JR
Biophys J; 2020 Jan; 118(2):303-312. PubMed ID: 31882250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
